Press release
Jul 26, 2023

Sosei Heptares Webinar Presentation for Q2 FY2023 Financial Results (Add a New Presenter)

Tokyo, Japan and Cambridge, UK, 26 July 2023 – Sosei Group Corporation (“the Company”; TSE: 4565) will announce its earnings results and present operational highlights for the 6 months ended 30 June 2023 on Friday, 4 August 2023.

The Company will host a live webinar presentation with Chris Cargill, President and CEO, Hironoshin Nomura, CFO, Matt Barnes, President of Heptares Therapeutics and Head of UK R&D and Satoshi Tanaka, President of Idorsia Pharmaceuticals Japan at 5 pm JST (9 am BST) on Friday, 4 August 2023. 

The webinar is open to all existing and potential investors as well as sell-/buy-side analysts and will consist of a presentation followed by a Q&A session. Please click here to pre-register, which will provide a link to access the webinar.


Presentation slides will be made available by 4 pm JST (8 am BST) on 4 August 2023 through the investor section of the Company’s Home Page here.


– ENDS –